HCC-derived CAFs have been shown to promote cancer cell proliferation and EMT through the overexpression of tissue transglutaminase-2 (TG2) and IL6/IL6R/STAT3 signaling [183]. Here, STAT3 is linked to hepatocellular carcinoma.